Plasma Exchange Combination of Immunosuppressive Regimens for Auto-immune

Updated 05/31/2024

Status Recruiting

Clinical Trial Summary

An open-label,pilot study to evaluate the efficacy and safety of plasma exchange combination of immunosuppressive regimens, for the remission of autoimmune hepatitis (AIH).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02874586
Study type	Interventional
Source	West China Hospital
Contact	Xiaoli Fan, MM
Phone	+862885422311
Status	Recruiting
Phase	N/A
Start date	December 2016
Completion date	September 2021

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT02994537` - Study of the Clinical Features of Autoimmune Hepatitis
	Recruiting	`NCT04617561` - Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II	Phase 4
	Recruiting	`NCT04376528` - Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy	Phase 4
	Not yet recruiting	`NCT05473403` - Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis	N/A
	Terminated	`NCT00286663` - Autoimmune Hepatitis Study	Phase 1
	Withdrawn	`NCT03593460` - Phase II AutoImmune Hepatitis	Phase 2
	Completed	`NCT03941184` - Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
	Completed	`NCT01980745` - CHLOROQUINE FOR MAINTENANCE REMISSION OF AUTOIMMUNE HEPATITIS	Phase 4
	Recruiting	`NCT03146884` - Swiss Autoimmune Hepatitis Cohort Study
	Recruiting	`NCT02997878` - Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH	Phase 1/Phase 2
	Recruiting	`NCT02936596` - Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome	N/A
	Withdrawn	`NCT02878863` - Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective Drugs Only for Auto-immune Hepatitis	Phase 3